A 48-year-old woman undergoes screening mammography and is found to have a 0.8 cm non-palpable lesion with suspicious microcalcifications (BI-RADS 4) in the left breast. Clinical examination is unremarkable. What is the most appropriate investigation to obtain tissue diagnosis?

Explanation

## Management of Non-Palpable Suspicious Breast Lesions **Key Point:** Stereotactic core needle biopsy is the gold standard for obtaining tissue diagnosis of non-palpable, mammographically-detected suspicious lesions. ### Why Stereotactic CNB is Optimal For non-palpable lesions identified only on mammography: 1. **Image-guided precision** — stereotactic guidance allows accurate needle placement using mammographic coordinates 2. **Minimally invasive** — outpatient procedure with low morbidity and cost 3. **High diagnostic accuracy** — >95% sensitivity for malignancy detection [cite:Robbins 10e Ch 24] 4. **Avoids unnecessary surgery** — eliminates need for diagnostic excisional biopsy in benign cases 5. **Adequate tissue sampling** — 14–18 gauge needles provide sufficient material for histological assessment ### Investigation Algorithm for Non-Palpable Lesions ```mermaid flowchart TD A[Non-palpable lesion on mammography]:::outcome --> B{BI-RADS assessment}:::decision B -->|BI-RADS 1-2| C[Routine screening]:::action B -->|BI-RADS 3| D[Short-term follow-up imaging] B -->|BI-RADS 4-5| E{Lesion characteristics?}:::decision E -->|Microcalcifications only| F[Stereotactic CNB]:::action E -->|Mass/distortion| G[Ultrasound evaluation]:::decision G -->|Visible on US| H[Ultrasound-guided CNB]:::action G -->|Not visible on US| F F --> I{Diagnosis confirmed?}:::decision I -->|Malignancy| J[Staging + treatment planning]:::action I -->|Benign| K[Imaging follow-up or discharge]:::action ``` ### Comparison of Biopsy Approaches for Non-Palpable Lesions | Approach | Guidance Method | Tissue Yield | Utility | Limitations | |---|---|---|---|---| | **Stereotactic CNB** | Mammographic coordinates | Excellent | Microcalcifications, mammographic densities | Requires prone positioning | | **Ultrasound-guided CNB** | Real-time US imaging | Excellent | Masses, architectural distortion | Lesion must be US-visible | | **Excisional Biopsy** | Wire localization | Complete lesion | Diagnostic uncertainty | Surgical, higher cost, scarring | | **FNA Cytology** | Ultrasound-guided | Limited cells | Cystic lesions | Poor sensitivity for solid lesions | **High-Yield:** BI-RADS 4 lesions have a 10–95% risk of malignancy and require tissue diagnosis. Stereotactic CNB is the standard approach for mammographically-detected microcalcifications because ultrasound cannot visualize microcalcifications reliably. **Clinical Pearl:** Microcalcifications are a hallmark of ductal carcinoma in situ (DCIS) and invasive ductal carcinoma. Their presence on mammography with BI-RADS 4 classification mandates tissue diagnosis, and stereotactic biopsy is the most direct and cost-effective route.